Article Text
Abstract
Background Cognitive improvement after endovascular embolization of an intracranial dural arteriovenous fistula (dAVF) remains unexplored. We aim to investigate cognitive changes following endovascular embolization of dAVFs.
Methods Neuropsychology in dural ArterIal Fistula (NAIF) was a prospective multicentric study including patients with an angiographic diagnosis of dAVF who underwent endovascular embolization over the course of 4 years. A complete neuropsychological evaluation comprising five cognitive domains (attention and executive functions, memory, language, praxis, gnosis) was performed at baseline and 3 months follow-up. Mean Z scores for cognitive tests were compared pre- and post-treatment using paired sample t-tests, where higher Z scores indicate better cognition. Effect sizes were computed as Cohen’s d.
Results A total of 32 patients (mean age 61.1±15.4 years, 10 (31.3%) females) were included. Patients exhibited improved performance in attention and executive functions: executive functions–attention (+0.282, P=0.009, d=0.29), executive functions–fluencies (+0.283, P=0.029, d=0.4), and executive functions–processing speed (+0.471, P=0.039, d=0.41). There was an increase in memory: verbal learning and verbal delayed recall scores (+0.513, P<0.001, d=0.55, and +0.385, P=0.001, d=0.41, respectively), while verbal recognition parameters (+0.839, P=0.086, d=0.37) and visual memory (delayed recall) (+0.430, P=0.060, d=0.35) displayed trends toward improved performance. Regarding language, there was significant overall improvement (+0.300, P=0.014, d=0.24), but neither praxis nor gnosis changed significantly. These cognitive outcomes were independent of the severity (measured as Cognard classification), and no patient experienced cognitive worsening.
Conclusion This study suggests that endovascular embolization confers cognitive benefits on dAVF patients undergoing endovascular embolization and may be beneficial even for patients with a low risk of hemorrhage.
- fistula
- arteriovenous malformation
- vascular malformation
- liquid embolic material
- embolic
Data availability statement
Data are available upon reasonable request.
Statistics from Altmetric.com
Data availability statement
Data are available upon reasonable request.
Footnotes
X @pedrovegavaldes, @Sremollo, @oscarsabino, @neuroplumber
Contributors LLG: concept, data analysis, drafting, and revising the manuscript and guarantor. GO: concept, data analysis, drafting, and revising the manuscript. LD, SA, SR, PV, AL, SR, AG, EM, OC, MM, MR, MdD, DH: data collection and analysis. MQ: concept, data analysis, drafting, and revising the manuscript. JP: data collection and analysis, drafting and revising the manuscript. AR: concept, data analysis, drafting, and revising the manuscript. AT: concept, data acquisition, and analysis, drafting and revising the manuscript.
Funding This study was supported by Medtronic. The supporter had no role in the design, conduct, collection, management, analysis, and interpretation of the data, preparation and approval of the manuscript
Competing interests This study was supported by Medtronic. The supporter had no role in the design, conduct, collection, management, analysis, and interpretation of the data, preparation and approval of the manuscript. Dr Gramegna had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Dr Tomasello has received personal fees from Anaconda Biomed, Balt, Medtronic, Perflow, and Stryker outside the submitted work. No other disclosures were reported.
Provenance and peer review Not commissioned; externally peer reviewed.